Varfydo 5 mg

    Varfydo 5 mg

    S4


    1. What VARFYDO is and what it is used for

    VARFYDO and VARFYDO 10 mg ODT contains an ingredient called vardenafil hydrochloride, a member of a class of medicines called phosphodiesterase type 5 inhibitors. They are prescribed for the treatment of erectile dysfunction in men. This is a condition where men have difficulties in achieving a penile erection hard enough for successful penetrative sex.

    2. What you need to know before you take VARFYDO

    Always tell your health care provider if you are taking any other medicine. Your doctor should consider your cardiovascular status, since there is a degree of heart risk associated with sexual activity. VARFYDO should not be used in men for whom sexual activity is not recommendable because of their underlying cardiovascular status. If sexual activity is not recommended for you due to some underlying heart condition, do not take VARFYDO.

    Do not take VARFYDO:

    • If you are hypersensitive (allergic) to vardenafil or any of the other ingredients of VARFYDO (listed in section 6)
    • If you are concurrently treated with nitrates or nitric oxide donors.
    • If you have ever had a condition involving loss of vision due to damage to the optic nerve from insufficient blood supply known as non-arteritic ischaemic optic neuropathy (NAION).
    • If you are suffering from end-stage kidney disease requiring dialysis.
    • If you are a woman or a child.
    • If you are suffering from sickle cell anaemia, multiple myeloma or leukaemia.
    • If you have anatomical deformation of the penis (such as angulation, cavernosal fibrosis or Peyronie’s disease).
    • If you are suffering from hypotension or low blood pressure (resting systolic blood pressure of < 90 mmHg).
    • If you are suffering from uncontrolled hypertension or high blood pressure (> 170/110 mmHg).
    • If you have a recent history of stroke, life-threatening irregular heart rhythm or heart attack (within last 6 months).
    • If you are suffering from uncontrolled cardiac (heart) failure.
    • If you suffer from unstable angina (chest pains as a result of lack of oxygen supply to the heart muscles).
    • If there is a known hereditary (family related) degenerative eye disorders such as progressive degeneration of the retina.
    • If you suffer from bleeding disorders.
    • If you suffer from active peptic ulcers.
    • If you suffer from severe impairment of liver function.
    • If you are currently taking the HIV protease inhibitors indinavir and ritonavir.
    • If you are over 75 years of age and are taking ketoconazole or itraconazole, anti-fungal medicines.
    • You suffer from moderate hepatic impairment.
    • You have phenylketonuria.
    • You have hereditary problems of lactose intolerance.

    If you are not at all sure, please consult your doctor.

    3. How to take VARFYDO

    Do not share medicines prescribed for you with any other person. Always take VARFYDO exactly as your doctor has instructed you. You should check with your doctor or pharmacist if you are not sure.

    Take VARFYDO by mouth. The usual dose is: The recommended daily dose range is 5 mg, or 10 mg, or 20 mg per day. The recommended starting dose of VARFYDO is 10 mg. Based on efficacy and tolerability; your dose may be increased to 20 mg or decreased to 5 mg. The maximum recommended dose is 20 mg once daily.

    VARFYDO 10 mg ODT is placed on the tongue and dissolves in the mouth in the presence of saliva. It should be taken immediately after release from the blister. It should be taken by itself without food or liquid in the mouth.

    Take VARFYDO as needed (approximately one hour) before sexual activity. However, you can take VARFYDO anytime from 25 minutes to at least up to 4 to 5 hours before sexual activity. Do not take more than one (1) tablet of VARFYDO per day. VARFYDO will not give you an instant erection; you will require sexual stimulation, either visual or physical, for an erection to occur after taking VARFYDO. You should swallow the whole tablet with some liquid. It can be taken with or without food, according to your preference. Do not crush the tablets.

    If you have the impression that the effect of VARFYDO is too strong or too weak, talk to your doctor or pharmacist.

    VARFYDO offers no protection against sexually transmitted diseases.

    If you take more VARFYDO than you should In the event of over dosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison control centre. In the event of overdosage, consult your doctor or pharmacist. If neither is available, seek help at the nearest hospital or poison control centre. You may experience severe back pain if you have taken an overdose of VARFYDO. In cases of overdose, your doctor or paramedics will take standard supportive measures as dictated by your clinical status.

    4. Possible side effects

    VARFYDO can have side effects. Not all side effects reported for VARFYDO are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking VARFYDO, please consult your doctor, pharmacist or other healthcare professional for advice.

    If any of the following happens, stop taking VARFYDO and tell your doctor immediately or go to the casualty department at your nearest hospital:

    • swelling of the hands, feet, ankles, face, lips and mouth or throat, which may cause difficulty in swallowing or breathing.
    • rash or itching
    • fainting

    These are all very serious side effects. If you have them, you may have had a serious reaction to VARFYDO. You may need urgent medical attention or hospitalization.

    If you experience sudden loss of vision while taking VARFYDO, you should stop treatment immediately and consult your doctor.

    Tell your doctor if you notice any of the following:

    Frequent side effects may include:

    • headache
    • dizziness
    • flushing (vasodilation)
    • blocked or runny nose
    • indigestion (dyspepsia)

    Less frequent side effects

    • swelling of the skin and mucous tissue including swollen face, lips or throat
    • sleep disorder
    • “pins and needles” and unpleasant sensation (paraesthesia and dysthesia), sleepiness
    • visual disturbances, redness of eyes or watery eyes (ocular hyperaemia)
    • sensitivity to light, colour distortion, eye pain and discomfort
    • ringing of ears (tinnitus), feeling off balance (vertigo)
    • palpitation, rapid heart rate (tachycardia)
    • breathlessness (dyspnoea), stuffy nose (sinus congestion)
    • nausea, stomach and abdominal pain, dry mouth, diarrhoea, acid reflux, gastritis
    • vomiting
    • increase in protein enzymes (transaminases)
    • inflammatory skin redness (erythema), rash
    • back pain, increase in the enzyme creatine phosphokinase, increased muscle tone and cramping, muscle pain (myalgia)
    • increase in erection
    • feeling unwell
    • conjunctivitis
    • allergic reaction
    • fainting (syncope) loss of memory (amnesia), seizure
    • increase in eye pressure (glaucoma)
    • effects on the heart such as angina pectoris, heart attack (myocardial infarction)
    • abnormal rapid heart rhythm that originates in the ventricles (ventricular tachyarrhythmias)
    • low blood pressure
    • prolonged and painful erection (priapism)
    • chest pain
    • nosebleed

    Frequency unknown

    • partial, sudden, temporary, or permanent loss in vision in one or both eyes
    • sudden decrease or loss of hearing
    • cerebral haemorrhage
    • Bleeding from the penis, blood in semen (haematospermia)
    • Retinal detachment (which may appear as tiny specks through your field of vision).

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    Reporting of side effects If you get side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects to SAHPRA via the “6.04 Adverse Drug Reaction Reporting Form”, found online under SAHPRA’s publications: https://www.sahpra.org.za/Publications/Index/8. By reporting side effects, you can help provide more information on the safety of VARFYDO.

    5. How to store VARFYDO

    Store at or below 25 ° C (room temperature). Protect from light. Keep the blisters in the carton until required for use. Keep the HDPE container tightly closed. Store in the original package in order to protect from light and moisture. KEEP OUT OF THE REACH OF CHILDREN. Do not store in a bathroom. Do not use after the expiry date stated on the blister / label / carton / bottle. Return all unused medicine to your pharmacist. Do not dispose of unused medicine in drains or sewerage systems (e.g. toilets).

    Important Disclaimer

    The Varfydo 5 mg professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Varfydo 5 mg
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites